Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin

doi:10.3748/wjg.v17.i4.493

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2798)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

439

HTML

2228

Tables (1-3)

131

Sum=2798

Jan 28, 2011 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 28, 2011; 17(4): 493-498
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.493

Table 2 Biochemical values pre-treatment and post-treatment (last sample of follow-up)

	Pre-treatment	Post-treatment	P
AST (IU/L)	73 ± 70	20 ± 5	< 0.001
ALT (IU/L)	138 ± 178	20 ± 9	< 0.001
ALP (IU/L)	70 ± 19	98 ± 55	< 0.001
GGT (IU/L)	51 ± 46	25 ± 20	< 0.001
AFP (ng/mL)	4.9 ± 4	3 ± 1	NS

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: γ-glutamyl transpeptidase; AFP: α-fetoprotein; NS: Not significant.

Citation: Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. World J Gastroenterol 2011; 17(4): 493-498
URL: https://www.wjgnet.com/1007-9327/full/v17/i4/493.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i4.493